Notícias

Oklo just reported its first-ever quarterly revenue.

Uranium Energy and Oklo stand to benefit from powerful tailwinds behind the nuclear energy industry, but only one stock stands out as a better play right now.

OKLO's Q2 performance reflects rising project execution costs, emerging acquisition-driven revenues and increased spending as nuclear development accelerates.

SMR's regulatory progress, supplier network and $1.9B liquidity support its outlook despite weak revenues and execution risks.

Oklo Inc. (NYSE:OKLO) just proved it can build a nuclear reactor as fast as it promised. On August 6, the company announced its Groves Isotope Test Reactor in Lockhart, Texas, achieved first criticality, a controlled, self-sustaining nuclear chain reaction, less than a year after groundbreaking. It’s the first project under the US Department of Energy’s […]

Oklo (NYSE:OKLO) announced a broad refresh of its executive leadership team, adding new heads across Product, Staff, Legal, Engineering, and Accounting. The company highlighted experience from organizations including the U.S. Nuclear Regulatory Commission, National Grid, and Joby Aviation among the new appointees. The reshaped leadership group is intended to support Oklo as it moves from pilot milestones toward commercial isotope production and closer regulatory engagement. For readers...

Oklo (NYSE:OKLO) reported a year-to-date net loss of $81.6 million through the second quarter of 2026 while outlining progress across its power, fuel and isotope businesses, including first criticality at its Groves isotope facility in Texas and continued development of its Aurora powerhouse project

What does $12 billion of market value buy when combined sales run about $12 million?

Centrus Energy (NYSE:LEU) reported second-quarter 2026 revenue growth and expanded its commercial backlog as the company advanced plans to build U.S. uranium-enrichment capacity for low-enriched uranium, or LEU, and high-assay low-enriched uranium, or HALEU. Revenue for the quarter ended June 30 ro

Groves facility reaches first criticality in under 11 months.

Moby summary of Oklo Inc.'s Q2 2026 earnings call

Oklo Inc (OKLO) reports a $81.6 million net loss but achieves first criticality at Groves facility and secures key DOE award, positioning for 2028 Aurora startup.

Energy stocks were lower late Friday afternoon, with the NYSE Energy Sector Index falling 1.1% and t

Oklo just posted its first real quarterly revenue and the stock surged, yet shares still sit 33% in the red for the year. A return to triple digits is mathematically possible, but it hinges on a very specific stack of catalysts falling into place.

Oklo achieved a crucial milestone.

Oklo (NYSE:OKLO) shares opened about 7% higher on Friday after the advanced nuclear technology company reported second quarter results that included a wider-than-expected loss but revenue that came in well above analyst estimates. The company reported a loss per share of $0.28, compared with...

Oklo posted revenue of $1.2 million in the second quarter, exceeding Street estimates of around $70,000, according to Fiscal.ai data

The benchmark US stock measures were tracking in the green before the open Friday as traders await a

Nonfarm payrolls fell by 23,000, marking the first monthly decline in employment in years

Oklo (OKLO) just reached first criticality at its Groves low power test reactor in Texas, achieving a controlled, self sustaining nuclear chain reaction less than a year after breaking ground. See our latest analysis for Oklo. Despite the Groves milestone, Oklo’s recent price action has been weak, with the share price down about 46% year to date and the 1 year total shareholder return also declining by about 47%, even after a strong multi year total shareholder return above 300%. If this kind...

With virtually no revenue line to judge, four things decide this report.

High expectations leave little room for disappointment.

Centrus Energy Corp (LEU) reports strong Q2 2026 results with revenue up 14% and a $4.5 billion backlog, driven by key HALEU agreements and a $900 million DOE task order.

Advanced nuclear startup Oklo achieved first criticality at its Groves Isotope Test Reactor in Texas in less than 12 months.

(Bloomberg) -- Oklo Inc.’s small modular reactor has reached a key milestone, the Energy Department announced Thursday.Most Read from BloombergIran Says Agreement on Hormuz Shipping Reached With OmanGoogle AI Veterans Depart During Seismic Leadership ShiftMicrosoft’s AI Sales Mostly Come From OpenAI, Disclosures ShowMajor Hedge Funds Targeted in Wave of Attempted CyberattacksWhy Do Data Centers Use So Much Fresh Water?Oklo’s Groves Isotope Test Reactor in Texas reached “criticality,” which occur

As OKLO gears up to report second-quarter earnings, let's find out how the expectations stack up. Also, know how to play the stock ahead of results.

A positive update on Oklo's reactor progress could reverse the nuclear stock's downward spiral.

Shares of Oklo have fallen close to 40% this year.

From Berkshire Hathaway to Oklo, there are plenty of ways to construct a diversified energy portfolio with $10,000.

Earnings continue to be the market's engine, and a series of results this week from Palantir, SpaceX, and AMD are set to rev up stocks again.